COVID-19 Outbreak-Global Oncology Molecular Diagnostics Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
SKU ID : Maia-15922673 | Publishing Date : 16-Jul-2020 | No. of pages : 117
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Oncology Molecular Diagnostics industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Oncology Molecular Diagnostics market can be split based on product types, major applications, and important countries as follows:
Key players in the global Oncology Molecular Diagnostics market covered in Chapter 12:
Agendia
Genomix Biotech
Rosetta Genomics
Cangen Biotechnologies
Kreatech Holding
Predictive Biosciences
Prediction Sciences
Eragen
Epigenomics
Genera Biosystems
BioMerieux
Nuvera Biosciences
SensiGen
Cepheid
Roche Diagnostics
Beckman Coulter
Genomic Health
QIAGEN
Becton.Dickinson and Company
Intergenetics
Orion Genomics
Health Discovery
Innogenetics
OncoMethylome Sciences
Asuragen
Vermillion
Autogenomics
EXACT Sciences
Abbott Diagnostics
HTG Molecular
Exiqon
Angsana Molecular and Diagnostics
Hologic
GeneNews
Source MDx
Diagnocure
Nanosphere
NorDiag
Myriad Genetics
In Chapter 4 and 14.1, on the basis of types, the Oncology Molecular Diagnostics market from 2015 to 2025 is primarily split into:
Instruments
Reagents
In Chapter 5 and 14.2, on the basis of applications, the Oncology Molecular Diagnostics market from 2015 to 2025 covers:
Breast
Colorectal
Prostate
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region